Our IL-6 and TNFα expression data are in agreement with the results reported by Yu et al. [7] who examined the cellular origin of IL-6 and TNFα in PCa patients utilizing quantitative reverse transcription PCR (q-RT-PCR) as well as chromogenic in situ hybridization (CISM) studies. The gene discussed is IL6; the disease is posterior cortical atrophy.